Cargando…
438. Phenotypic Differences Between Distinct Immune Biomarker Clusters During the ‘Hyperinflammatory’ Middle-Phase of COVID-19
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections peak during an inflammatory ‘middle’ phase and lead to severe illness predominately among those with certain comorbid noncommunicable diseases (NCDs). We used network machine learning to identify inflammation biomark...
Autores principales: | Blair, Paul W, Brandsma, Joost, Epsi, Nusrat J, Richard, Stephanie A, Striegel, Deborah, Chenoweth, Josh, Mehta, Rittal, Clemens, Emily, Malloy, Allison, Lanteri, Charlotte, Dumler, J Stephen, Tribble, David, Burgess, Timothy, Pollett, Simon, Agan, Brian, Clark, Danielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644901/ http://dx.doi.org/10.1093/ofid/ofab466.637 |
Ejemplares similares
-
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19
por: Blair, Paul W., et al.
Publicado: (2022) -
508. Biomarker elevation during COVID-19: Differences between ambulatory and hospitalized individuals
por: Blair, Paul W, et al.
Publicado: (2020) -
461. Classical Antigen Presenting Cell Activation Correlates with T Cell Immunity and COVID-19 Severity
por: Lu, Zhongyan, et al.
Publicado: (2021) -
Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
por: Brandsma, Joost, et al.
Publicado: (2022) -
434. Characteristics and long-term outcomes of SARS-CoV-2 associated myocarditis cases in the Military Health System
por: Pollett, Simon, et al.
Publicado: (2023)